Optimind looks to accelerate the adoption of the MindSetting(TM) TRIP Protocol for ketamine-assisted therapy and other psychedelic enhanced psychotherapy modalities. Toronto, Ontario--(Newsfile Corp. ...

Toronto, Ontario--(Newsfile Corp. - July 29, 2022) - Optimind Pharma Corp. ("Optimind" or the "Company") announces the successful closing of its previously announced reverse takeover ("RTO") of Loon ...

Redefining Recruitment with AI, Data, and Human Intelligence Monjin is advancing talent acquisition by uniquely blending advanced artificial intelligence, big data, and a global network of expert ...

AUSTIN, Texas--(BUSINESS WIRE)--OptiMind, the breakthrough premium nootropic from direct to consumer health company AlternaScript, is improving brain function for thousands of dedicated consumers with ...

Manitari Pharma received approval to begin construction of Security Level 3 safe plus grow rooms, Manitari Pharma is one step closer to obtaining Controlled Substances Dealer's Licence for Psilocybin ...

TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into an acquisition agreement dated October 12 ...

TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the "Optimind" or the "Company") advises that it has reached agreement with holders of principal amount $303,750 ...

Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - Optimind Pharma Corp. (CSE: OMND) (the "Company") wishes to announce that pursuant to its stock option plan, it has granted stock options to its ...

to be able to take the mind, our brain’s ability, to another level. OptiMind’s ingredients were grown ethically, with a high level of scrutiny for quality control, and tested through clinical studies.